[1]
Kania, K., Kania, J., Niekurzak, K., Jędrak, M., Józefiak, M. and Sobkiewicz, P. 2023. FDA Approves Omaveloxolone based on Successful Moxie Trial Results for Friedreich’s Ataxia - Review. Journal of Education, Health and Sport. 40, 1 (Aug. 2023), 111–126. DOI:https://doi.org/10.12775/JEHS.2023.40.01.010.